Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Combinations of inhaled long-acting bronchodilator therapies such as muscarinic antagonists
and β2-agonists may be more effective than monotherapy in the treatment of chronic
obstructive pulmonary disease (COPD).